News

  • American Clinical Laboratory Association Supports Senate Passage of Provisions for Clinical Laboratory Fee Schedule in SGR Extension Legislation

    April 01, 2014
    WASHINGTON, D.C. – The American Clinical Laboratory Association (ACLA) – a not-for-profit association representing the nation’s leading national and regional clinical laboratories on key federal and state government reimbursement and regulatory policies – voiced support for provisions in the SGR extension legislation passed by the U.S. Senate today that reform the Clinical Laboratory Fee Schedule (CLFS) by providing a more rational process for transitioning toContinue Reading »...
  • A Statement from the American Clinical Laboratory Association (ACLA) on the Clinical Laboratory Fee Schedule (CLFS) provisions in the SGR Extension Legislation

    March 26, 2014
    WASHINGTON, D.C. – The American Clinical Laboratory Association (ACLA) — a not-for-profit association representing the nation’s leading national and regional clinical laboratories on key issues of common concern, including federal and state government reimbursement and regulatory policies –issued the following statement regarding the Clinical Laboratory Fee Schedule (CLFS) provisions in the SGR extension legislation that was posted in the US House of Representatives earlierContinue Reading »...
  • American Clinical Laboratory Association Names Steve Rusckowski, CEO of Quest Diagnostics, as New Chairman of the Board

    March 24, 2014
    WASHINGTON, D.C. –   The American Clinical Laboratory Association (ACLA) announced it has approved the nomination of Quest Diagnostics CEO Stephen H. Rusckowski, as Chairman of the Board for the national association representing clinical laboratories. Mr. Rusckowski was nominated by the ACLA Board of Directors and approved by the membership during ACLA’s annual conference. “Clinical laboratory testing provides insights that help improve healthcare decision making,Continue Reading »...
  • Importance of Clinical Lab Testing for Patients At Risk of Chronic Kidney Disease Heralded During National Kidney Month

    March 21, 2014
      WASHINGTON, D.C. – Noting the critical role routine clinical lab tests play in the diagnosis of Chronic Kidney Disease (CKD) and many other diseases – such as diabetes and high blood pressure – that may lead to or develop following a CKD diagnosis, the American Clinical Laboratory Association (ACLA) today recognized National Kidney Month this March as a time to increase education andContinue Reading »...
  • ACLA and G2 Intelligence Hold Webinar On CMS Rule Allowing Patients’ Direct Access to Lab Results

    March 20, 2014
    WASHINGTON, D.C. –  In order to provide perspective and impact analysis for clinical laboratory professionals regarding a recently announced rule by the Centers for Medicare and Medicaid Services (CMS) that would allow consumers direct access to their lab results, the American Clinical Laboratory Association (ACLA) and G2 Intelligence, an organization reporting on the diagnostic industry for more than 30 years, will sponsor a webinarContinue Reading »...
  • ACLA FISH NCCI Policy Change – Meeting follow-up letter

    March 19, 2014
    March 19, 2014 Dr. Daniel Duvall, Medical Officer Center for Medicare, Hospital and Ambulatory Policy Group Centers for Medicare and Medicaid Services 7500 Security Boulevard Baltimore, Maryland  21244 Dr. Edith Hambrick, Medical Officer Center for Medicare, Hospital and Ambulatory Policy Group Centers for Medicare and Medicaid Services 7500 Security Boulevard Baltimore, Maryland  21244 Ms. Linda Smith, Director, Analytics Lab Division Center for Program IntegrityContinue Reading »...
  • American Clinical Laboratory Association Addresses Medicare Reimbursement Challenges at 2014 Annual Meeting

    March 18, 2014
    Washington, D.C. –  The American Clinical Laboratory Association (ACLA) today opened its 19th Annual Meeting entitled “Navigating the Reimbursement Maze: Challenges and Opportunities Facing Laboratories in the 21st Century,” drawing over 100 clinical laboratory professionals from across the country and featuring health policy experts that will address regulatory policy and funding challenges impacting clinical laboratories.   “As an industry, clinical labs provide the mostContinue Reading »...
  • ‘No rationale’ for Tricare’s refusal to cover genetic tests

    March 11, 2014
    A change in medical classifications last year has left clinical laboratories across the U.S. carrying a $10 million tab for Tricare. Tricare beneficiaries have not been billed for certain physician-ordered tests they have received at clinical laboratories since Jan. 1, 2013 — but Tricare also has not paid for them. At the heart of the standoff are genetic tests developed by laboratories that areContinue Reading »...
  • Innovation must be part of the cost evaluation of healthcare

    March 11, 2014
    Arguments can be made on both sides about access and quality, when comparing our healthcare system to the rest of the industrialized world. But, few would dispute that American healthcare is the most innovative in the world. In fact, the creativity and expertise of American manufacturers, doctors, hospitals and Academic Medical Centers, laboratories, drug companies, health IT companies, and other participants set the standardContinue Reading »...
  • ACLA on President’s FY 2015 Budget

    March 04, 2014
    (Washington, D.C.) – The American Clinical Laboratory Association (ACLA) today pointed to both beneficial and harmful provisions in the President’s FY 2015 budget: drastic funding cuts that would compromise the continued delivery of high quality clinical lab services to Medicare beneficiaries and a proposal that would preserve integrity in the lab services industry. ACLA urged congressional budget leaders to oppose provisions that would reduceContinue Reading »...